Division of Hematology and Oncology

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

The project seeks to reduce the time for clinical chart abstraction by 90% while maintaining human-level accuracy.

Launched Sept. 17-19 during the World Cancer Congress in Geneva, Switzerland, “Rewriting Cancer” aims to enhance understanding and inspire audiences by exploring the most innovative, inclusive and impactful solutions for cancer prevention, diagnosis, treatment and care globally.

The findings were so promising that the clinical trial is being redesigned to investigate whether radiation treatment can also be avoided.

The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments.

This new entry to the field works in the background to provide real-time risk assessments, with no manual inputs from health care providers required.

The authors hope the report will provide insight on the importance of education, screening and awareness to all health care providers.